These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 10076592)

  • 1. Clinically useful monoclonal antibodies in treatment.
    Drewe E; Powell RJ
    J Clin Pathol; 2002 Feb; 55(2):81-5. PubMed ID: 11864998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection.
    Long R; Gardam M
    CMAJ; 2003 Apr; 168(9):1153-6. PubMed ID: 12719321
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working group.
    Lochs H; Adler G; Beglinger C; Duchmann R; Emmrich J; Ewe K; Gangl A; Gasché C; Hahn E; Hoffmann P; Kaskas B; Malchow H; Pohl C; Raedler A; Renner E; Schölmerich J; Schreiber S; Stange E; Tilg H; Vogelsang H; Weigert N; Zeitz M
    Z Gastroenterol; 1999 Jun; 37(6):509-12. PubMed ID: 10427657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab: new indication. Severe Crohn's disease in children: many unknowns.
    Prescrire Int; 2008 Aug; 17(96):145. PubMed ID: 19489184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab: new indication. Severe Crohn's disease: a second TNF alpha antagonist, subcutaneous administration.
    Prescrire Int; 2008 Aug; 17(96):137. PubMed ID: 19480092
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab (Remicade) for Crohn's disease.
    Med Lett Drugs Ther; 1999 Feb; 41(1047):19-20. PubMed ID: 10076592
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab therapy in Crohn's disease: safety issues.
    Hommes DW; van Deventer SJ
    Neth J Med; 2003 Apr; 61(4):100-4. PubMed ID: 12852717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
    Loftus EV
    Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
    [No Abstract]   [Full Text] [Related]  

  • 10. Infliximab (Remicade), a new biological treatment for Crohn's disease.
    D'Haens GR
    Ital J Gastroenterol Hepatol; 1999; 31(6):519-20. PubMed ID: 10575573
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.